Lawrence Cameron William 4
4 · ONCOGENEX PHARMACEUTICALS, INC. · Filed Nov 10, 2010
Insider Transaction Report
Form 4
Lawrence Cameron William
Principal Financial Officer
Transactions
- Purchase
Common Stock
2010-11-09$15.73/sh+650$10,225→ 3,050 total(indirect: RRSP)
Holdings
- 475(indirect: By Spouse)
Common Stock